Methadone and Metabolites, Confirmation, Urine
Methadone is a synthetic opioid agonist that became popular as an agent for detoxification and maintenance of individuals with narcotic addiction, but is now widely used for managing chronic pain around the clock. One of the advantages that methadone has over other opioid agonists is the fact that methadone is very effective when given orally and the duration of its therapeutic effect is long-lasting. Another advantage is that the withdrawal effect of methadone is milder than other antagonist drugs. The typical route of administration is oral. Most methadone is supplied in a racemic mixture of which the levorotary (r-) enantiomer is the opioid agonist. The dextromethadone enantiomer is an NMDA antagonist. Methadone is metabolized extensively but the major metabolite that appears in the urine is 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP). The half-life of methadone is 15-55 hours.
Methadone and EDDP appear in the urine at near equal concentrations unless the urine is acidified, in which case the unchanged methadone predominates. There is large individual variation in the actual concentrations and proportion of dosing that is eliminated in the urine over a specific time period. Actual elimination depends on factors such as drug formulation, dose, dose frequency, clinical status and pharmacokinetics of the individual patient.
Common side effects: respiratory depression, sedation, nausea, vomiting, dizziness, miosis, constipation, urinary retention. Methadone can also contribute to the following effects: QTc interval prolongation, arrythmias, mental clouding, amnesia, hostility, irritability, pruritis, and vivid or disturbing dreams. Can be addictive. Overdose effects include respiratory collapse, seizure, coma, and possible death. Accidental deaths are a major concern with methadone.
Methadone can be analyzed in urine by a variety of analytical methods (see below); both qualitative and quantitative tests are available.
- Adherence monitoring
- Drug abuse evaluation
- Toxicity/Overdose assessment
Therapeutic Level: 10-100 ng/ml
Toxic level: >200 ng/ml
Note: therapeutic ranges and toxic thresholds are best evaluated from blood samples. Quantitative results obtained with blood samples collected at specific times after drug administration are preferred for pharmacokinetic analyses.
Cut-Off Ranges
Cut-off values are used to determine the positivity of the urine specimen being analyzed. Cut-off values can vary based on the particular method of analysis that is used for detection, or laboratory, whether the test is a qualitative method or a quantitative method. The testing laboratory cut-off range is listed on the patient report.
Fresh urine specimen (random) collected in either a clean glass or plastic container. An acceptable urine specimen submitted for testing should be in the pH range of 3-11. Creatinine or specific gravity results will identify dilute specimens. Adulteration of the urine specimen can result in erroneous results.
Stability
- Ambient: 3-5 days
- Refrigeration: 7-14 days
- Frozen: 30 days
- Baselt RC (ed). Disposition of toxic drugs and chemicals in man, 9th ed. Foster City, CA: Biomedical Publications; 2011.
- Brunton LL, Chabner B, Knollman B (eds). Goodman and Gilmans’ the pharmacological basis of therapeutics, 12th ed. New York: McGraw-Hill; 2010.
- Katzung BG, Masters S, Trevor AK (eds). Basic and clinical pharmacology, 12th ed. New York: McGraw-Hill; 2011.